vs
bioAffinity Technologies, Inc.（BIAF）与ICON PLC（ICLR）财务数据对比。点击上方公司名可切换其他公司
ICON PLC的季度营收约是bioAffinity Technologies, Inc.的1282.5倍（$2.0B vs $1.6M）。ICON PLC净利率更高（0.1% vs -197.0%，领先197.1%）。ICON PLC同比增速更快（0.6% vs -27.8%）。ICON PLC自由现金流更多（$333.9M vs $-2.6M）。过去两年ICON PLC的营收复合增速更高（0.6% vs -18.6%）
bioAffinity Technologies是一家处于临床阶段的生物技术企业，专注于研发可用于癌症、呼吸系统疾病早期检测的非侵入性体外诊断产品，面向全球医疗市场，致力于提供高准确率的便捷诊断方案，改善患者诊疗体验与预后效果。
ICON plc是总部位于爱尔兰的跨国医疗智能与临床研究服务机构，专注为全球医药健康领域客户提供专业研究及情报支持，截至2025年2月，已在全球55个国家布局业务，员工规模约4.19万人。
BIAF vs ICLR — 直观对比
营收规模更大
ICLR
是对方的1282.5倍
$1.6M
营收增速更快
ICLR
高出28.5%
-27.8%
净利率更高
ICLR
高出197.1%
-197.0%
自由现金流更多
ICLR
多$336.5M
$-2.6M
两年增速更快
ICLR
近两年复合增速
-18.6%
损益表 — Q4 2025 vs Q3 2025
| 指标 | | |
|---|---|---|
| 营收 | $1.6M | $2.0B |
| 净利润 | $-3.1M | $2.4M |
| 毛利率 | — | — |
| 营业利润率 | -196.9% | 4.2% |
| 净利率 | -197.0% | 0.1% |
| 营收同比 | -27.8% | 0.6% |
| 净利润同比 | -5.7% | -98.8% |
| 每股收益（稀释后） | $-3.59 | $0.03 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BIAFICLR
| Q4 25 | $1.6M | — | ||
| Q3 25 | $1.4M | $2.0B | ||
| Q2 25 | $1.3M | $2.0B | ||
| Q1 25 | $1.9M | $2.0B | ||
| Q4 24 | $2.2M | — | ||
| Q3 24 | $2.4M | $2.0B | ||
| Q2 24 | $2.4M | $2.1B | ||
| Q1 24 | $2.4M | $2.1B |
净利润BIAFICLR
| Q4 25 | $-3.1M | — | ||
| Q3 25 | $-5.1M | $2.4M | ||
| Q2 25 | $-4.1M | $183.0M | ||
| Q1 25 | $-2.7M | $154.2M | ||
| Q4 24 | $-3.0M | — | ||
| Q3 24 | $-2.0M | $197.1M | ||
| Q2 24 | $-2.1M | $146.9M | ||
| Q1 24 | $-2.0M | $187.4M |
营业利润率BIAFICLR
| Q4 25 | -196.9% | — | ||
| Q3 25 | -158.6% | 4.2% | ||
| Q2 25 | -198.2% | 10.4% | ||
| Q1 25 | -141.7% | 11.0% | ||
| Q4 24 | -133.5% | — | ||
| Q3 24 | -84.0% | 14.1% | ||
| Q2 24 | -87.1% | 10.8% | ||
| Q1 24 | -80.8% | 13.7% |
净利率BIAFICLR
| Q4 25 | -197.0% | — | ||
| Q3 25 | -349.3% | 0.1% | ||
| Q2 25 | -319.9% | 9.1% | ||
| Q1 25 | -143.5% | 7.7% | ||
| Q4 24 | -134.4% | — | ||
| Q3 24 | -85.1% | 9.7% | ||
| Q2 24 | -88.0% | 6.9% | ||
| Q1 24 | -81.5% | 9.0% |
每股收益（稀释后）BIAFICLR
| Q4 25 | $-3.59 | — | ||
| Q3 25 | $-4.74 | $0.03 | ||
| Q2 25 | $-0.17 | $2.30 | ||
| Q1 25 | $-0.16 | $1.90 | ||
| Q4 24 | $-17.27 | — | ||
| Q3 24 | $-4.84 | $2.36 | ||
| Q2 24 | $-0.19 | $1.76 | ||
| Q1 24 | $-0.20 | $2.25 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $6.4M | $468.9M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $7.3M | $9.3B |
| 总资产 | $11.0M | $16.5B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资BIAFICLR
| Q4 25 | $6.4M | — | ||
| Q3 25 | $7.7M | $468.9M | ||
| Q2 25 | $802.8K | $390.4M | ||
| Q1 25 | $444.7K | $526.7M | ||
| Q4 24 | $1.1M | — | ||
| Q3 24 | $756.6K | $695.5M | ||
| Q2 24 | $801.3K | $506.6M | ||
| Q1 24 | $2.5M | $396.1M |
股东权益BIAFICLR
| Q4 25 | $7.3M | — | ||
| Q3 25 | $8.9M | $9.3B | ||
| Q2 25 | $-2.1M | $9.6B | ||
| Q1 25 | $1.4M | $9.5B | ||
| Q4 24 | $2.6M | — | ||
| Q3 24 | $3.1M | $9.8B | ||
| Q2 24 | $3.4M | $9.6B | ||
| Q1 24 | $5.3M | $9.4B |
总资产BIAFICLR
| Q4 25 | $11.0M | — | ||
| Q3 25 | $11.5M | $16.5B | ||
| Q2 25 | $4.8M | $16.6B | ||
| Q1 25 | $5.5M | $16.7B | ||
| Q4 24 | $6.5M | — | ||
| Q3 24 | $6.6M | $17.2B | ||
| Q2 24 | $6.7M | $17.0B | ||
| Q1 24 | $8.0M | $17.0B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-2.6M | $387.6M |
| 自由现金流经营现金流 - 资本支出 | $-2.6M | $333.9M |
| 自由现金流率自由现金流/营收 | -160.7% | 16.3% |
| 资本支出强度资本支出/营收 | 0.0% | 2.6% |
| 现金转化率经营现金流/净利润 | — | 164.59× |
| 过去12个月自由现金流最近4个季度 | $-9.4M | $1.0B |
8季度趋势，按日历期对齐
经营现金流BIAFICLR
| Q4 25 | $-2.6M | — | ||
| Q3 25 | $-2.5M | $387.6M | ||
| Q2 25 | $-2.6M | $146.2M | ||
| Q1 25 | $-1.6M | $268.2M | ||
| Q4 24 | $-1.7M | — | ||
| Q3 24 | $-1.7M | $402.7M | ||
| Q2 24 | $-1.5M | $218.6M | ||
| Q1 24 | $-2.3M | $327.1M |
自由现金流BIAFICLR
| Q4 25 | $-2.6M | — | ||
| Q3 25 | $-2.5M | $333.9M | ||
| Q2 25 | $-2.7M | $113.9M | ||
| Q1 25 | $-1.7M | $239.3M | ||
| Q4 24 | $-1.7M | — | ||
| Q3 24 | $-1.7M | $359.3M | ||
| Q2 24 | $-1.6M | $182.3M | ||
| Q1 24 | $-2.4M | $299.9M |
自由现金流率BIAFICLR
| Q4 25 | -160.7% | — | ||
| Q3 25 | -171.8% | 16.3% | ||
| Q2 25 | -209.6% | 5.6% | ||
| Q1 25 | -91.3% | 12.0% | ||
| Q4 24 | -76.0% | — | ||
| Q3 24 | -73.1% | 17.7% | ||
| Q2 24 | -65.1% | 8.6% | ||
| Q1 24 | -99.2% | 14.3% |
资本支出强度BIAFICLR
| Q4 25 | 0.0% | — | ||
| Q3 25 | 0.3% | 2.6% | ||
| Q2 25 | 1.1% | 1.6% | ||
| Q1 25 | 2.7% | 1.4% | ||
| Q4 24 | 0.0% | — | ||
| Q3 24 | 0.4% | 2.1% | ||
| Q2 24 | 1.2% | 1.7% | ||
| Q1 24 | 1.7% | 1.3% |
现金转化率BIAFICLR
| Q4 25 | — | — | ||
| Q3 25 | — | 164.59× | ||
| Q2 25 | — | 0.80× | ||
| Q1 25 | — | 1.74× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 2.04× | ||
| Q2 24 | — | 1.49× | ||
| Q1 24 | — | 1.74× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BIAF
暂无分部数据
ICLR
| Other Customers | $681.3M | 33% |
| Clients1125 | $549.4M | 27% |
| Clients15 | $503.3M | 25% |
| Clients610 | $308.8M | 15% |
